Lexeo Therapeutics, Inc.
LXEO
$4.61
-$0.12-2.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -48.82% | 0.04% | 342.95% | 284.24% | 152.23% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 79.70% | 62.77% | 72.42% | 12.10% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -46.86% | 1.47% | 310.19% | 263.67% | -- |
|
|
|||||
| Total Current Assets | -46.86% | 1.47% | 310.19% | 263.67% | -- |
| Net Property, Plant & Equipment | -14.59% | -13.90% | -11.45% | -10.55% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.12% | 0.00% | 0.00% | 0.00% | -- |
| Total Assets | -41.05% | 5.10% | 217.71% | 195.67% | -- |
|
|
|||||
| Total Accounts Payable | 178.82% | 69.14% | 217.82% | 143.35% | -- |
| Total Accrued Expenses | 7.85% | 24.64% | 12.70% | 43.81% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.38% | 2.50% | 3.27% | -4.40% | -- |
| Total Finance Division Other Current Liabilities | 105.21% | 69.49% | 179.80% | -84.17% | -- |
| Total Other Current Liabilities | 105.21% | 69.49% | 179.80% | -84.17% | -- |
| Total Current Liabilities | 42.50% | 32.53% | 16.42% | 38.19% | -- |
|
|
|||||
| Total Current Liabilities | 42.50% | 32.53% | 16.42% | 38.19% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -21.72% | -19.69% | -18.42% | -17.06% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.19% | 14.57% | 6.28% | 15.02% | -- |
|
|
|||||
| Common Stock & APIC | 3.76% | 34.45% | 8,023.59% | 9,826.67% | -- |
| Retained Earnings | -53.71% | -54.08% | -51.65% | -52.33% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -51.84% | 2.91% | 185.58% | 214.85% | 261.97% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -51.84% | 2.91% | 185.58% | 214.85% | 261.97% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -51.84% | 2.91% | 526.89% | 298.29% | 153.82% |
|
|
|||||